PL1757610T3 - Skondensowana pochodna pirymidyny oraz inhibitor oksydazy ksantynowej - Google Patents
Skondensowana pochodna pirymidyny oraz inhibitor oksydazy ksantynowejInfo
- Publication number
- PL1757610T3 PL1757610T3 PL05751417T PL05751417T PL1757610T3 PL 1757610 T3 PL1757610 T3 PL 1757610T3 PL 05751417 T PL05751417 T PL 05751417T PL 05751417 T PL05751417 T PL 05751417T PL 1757610 T3 PL1757610 T3 PL 1757610T3
- Authority
- PL
- Poland
- Prior art keywords
- xanthine oxidase
- oxidase inhibitor
- pyrimidine derivative
- carbon atoms
- condensed pyrimidine
- Prior art date
Links
- 229940123769 Xanthine oxidase inhibitor Drugs 0.000 title abstract 2
- 239000003064 xanthine oxidase inhibitor Substances 0.000 title abstract 2
- 150000003230 pyrimidines Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 239000011593 sulfur Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004175798 | 2004-06-14 | ||
| PCT/JP2005/011188 WO2005121153A1 (ja) | 2004-06-14 | 2005-06-13 | 縮合ピリミジン誘導体、及びキサンチンオキシダーゼ阻害剤 |
| EP05751417A EP1757610B1 (en) | 2004-06-14 | 2005-06-13 | Condensed pyrimidine derivative and xanthine oxidase inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1757610T3 true PL1757610T3 (pl) | 2011-10-31 |
Family
ID=35503006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05751417T PL1757610T3 (pl) | 2004-06-14 | 2005-06-13 | Skondensowana pochodna pirymidyny oraz inhibitor oksydazy ksantynowej |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7598254B2 (pl) |
| EP (1) | EP1757610B1 (pl) |
| JP (3) | JP4914210B2 (pl) |
| CN (1) | CN1993367B (pl) |
| AT (1) | ATE512154T1 (pl) |
| DK (1) | DK1757610T3 (pl) |
| ES (1) | ES2367118T3 (pl) |
| PL (1) | PL1757610T3 (pl) |
| PT (1) | PT1757610E (pl) |
| WO (1) | WO2005121153A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE512154T1 (de) * | 2004-06-14 | 2011-06-15 | Nippon Chemiphar Co | Kondensiertes pyrimidinderivat und xanthinoxidaseinhibitor |
| US20090149452A1 (en) * | 2005-07-01 | 2009-06-11 | Nippon Chemiphar Co., Ltd. | Xanthine oxidase inhibitor |
| AU2007261923B2 (en) | 2006-06-22 | 2013-10-31 | Nippon Chemiphar Co., Ltd. | Agent for overcoming resistance to anti-cancer agent |
| JP5907396B2 (ja) | 2012-10-23 | 2016-04-26 | 国立大学法人福井大学 | 腫瘍融解症候群の治療薬及び予防薬 |
| CN103848798B (zh) | 2012-11-30 | 2016-01-06 | 镇江新元素医药科技有限公司 | 2-芳基硒唑化合物及其药物组合物 |
| CN105579037A (zh) | 2013-05-31 | 2016-05-11 | 武田制药美国有限公司 | 用黄嘌呤氧化酶抑制剂治疗的方法和含黄嘌呤氧化酶抑制剂的组合物 |
| US10413546B2 (en) | 2015-02-24 | 2019-09-17 | National University Corporation Tottori University | Drug for preventing and/or treating dementia |
| TWI780270B (zh) | 2017-11-28 | 2022-10-11 | 靜岡縣公立大學法人 | 固體分散體 |
| JP2021127289A (ja) * | 2018-04-27 | 2021-09-02 | 日本ケミファ株式会社 | 縮合ピリミジン誘導体 |
| WO2020246526A1 (ja) | 2019-06-04 | 2020-12-10 | 日本ケミファ株式会社 | キサンチンオキシダーゼ阻害剤含有腸溶性製剤 |
| JPWO2020246528A1 (pl) | 2019-06-04 | 2020-12-10 | ||
| EP4260860A1 (en) | 2020-12-08 | 2023-10-18 | School Juridical Person Higashi-Nippon-Gakuen | Intracellular atp enhancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6421431A (en) | 1987-07-16 | 1989-01-24 | Fuji Photo Film Co Ltd | Film carrying device |
| JP2691317B2 (ja) * | 1989-08-25 | 1997-12-17 | 株式会社大塚製薬工場 | ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法 |
| DE122008000051I1 (de) * | 1990-11-30 | 2009-02-05 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
| ID21775A (id) | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| JP2000001431A (ja) * | 1998-06-15 | 2000-01-07 | Kotobuki Seiyaku Kk | 尿酸排泄剤 |
| EP1452528B1 (en) * | 2001-11-16 | 2008-08-13 | Nippon Chemiphar Co., Ltd. | Xanthine oxidase inhibitors |
| ATE512154T1 (de) * | 2004-06-14 | 2011-06-15 | Nippon Chemiphar Co | Kondensiertes pyrimidinderivat und xanthinoxidaseinhibitor |
-
2005
- 2005-06-13 AT AT05751417T patent/ATE512154T1/de active
- 2005-06-13 US US11/629,277 patent/US7598254B2/en active Active
- 2005-06-13 JP JP2006514620A patent/JP4914210B2/ja active Active
- 2005-06-13 EP EP05751417A patent/EP1757610B1/en active Active
- 2005-06-13 ES ES05751417T patent/ES2367118T3/es active Active
- 2005-06-13 DK DK05751417.6T patent/DK1757610T3/da active
- 2005-06-13 PL PL05751417T patent/PL1757610T3/pl unknown
- 2005-06-13 PT PT05751417T patent/PT1757610E/pt unknown
- 2005-06-13 WO PCT/JP2005/011188 patent/WO2005121153A1/ja active Application Filing
- 2005-06-13 CN CN2005800267399A patent/CN1993367B/zh active Active
-
2011
- 2011-12-16 JP JP2011276232A patent/JP5456757B2/ja active Active
-
2013
- 2013-06-03 JP JP2013117370A patent/JP5554439B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013189460A (ja) | 2013-09-26 |
| EP1757610A4 (en) | 2009-06-24 |
| US20070293512A1 (en) | 2007-12-20 |
| JPWO2005121153A1 (ja) | 2008-04-10 |
| ES2367118T3 (es) | 2011-10-28 |
| DK1757610T3 (da) | 2011-08-01 |
| CN1993367B (zh) | 2012-05-30 |
| US7598254B2 (en) | 2009-10-06 |
| JP2012092128A (ja) | 2012-05-17 |
| WO2005121153A1 (ja) | 2005-12-22 |
| JP5456757B2 (ja) | 2014-04-02 |
| JP5554439B2 (ja) | 2014-07-23 |
| PT1757610E (pt) | 2011-08-24 |
| JP4914210B2 (ja) | 2012-04-11 |
| EP1757610B1 (en) | 2011-06-08 |
| ATE512154T1 (de) | 2011-06-15 |
| EP1757610A1 (en) | 2007-02-28 |
| CN1993367A (zh) | 2007-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1757610A4 (en) | CONDENSED PYRIMIDINE DERIVATIVE AND XANTHINEOXIDASEINHIBITOR | |
| DK1452528T3 (da) | Xanthinoxidaserinhibitorer | |
| EP1338595A3 (en) | Xanthine derivatives as DPP-IV inhibitors | |
| WO2006123165A3 (en) | Pyrimidine derivatives as hsp90 inhibitors | |
| WO2006062982A3 (en) | Urea inhibitors of map kinases | |
| WO2007026920A3 (en) | Amide derivatives as rock inhibitors | |
| DE602006007012D1 (de) | Pyridinderivate als dipeptedyl-peptidase-hemmer | |
| WO2007056159A3 (en) | Hydrazone derivatives and uses thereof | |
| WO2004071440A3 (en) | Thiazolyl-based compounds useful as kinase inhibitors | |
| AR042602A1 (es) | Compuestos de 1,2,4-triazol | |
| ATE449099T1 (de) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
| WO2007003934A3 (en) | 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors | |
| WO2008076779A3 (en) | 2-(piperidin-4-yl0xy)pyrimidin-4-amine derivatives as deoxycytidine kinase inhibitors for the treatment of cancer | |
| ATE540928T1 (de) | Isochinolinverbindungen und ihre medizinische verwendung | |
| PE20080835A1 (es) | Derivados novedosos de aminopiridina que tienen accion inhibidora selectiva sobre aurora a | |
| WO2008126901A1 (ja) | 含窒素複素環化合物およびそれを含有する医薬組成物 | |
| PE20011115A1 (es) | Etanos tri-aril-sustituidos inhibidores de pde4 | |
| ATE172452T1 (de) | Bicyclische stichstoff enthaltende derivate als prolyl-endopeptidase inhibitoren | |
| WO2007081690A3 (en) | Inhibitors of protein kinases | |
| WO2003099206A3 (en) | Indole compounds useful as impdh inhibitors | |
| EA200600018A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов фдэ4 | |
| ATE445619T1 (de) | Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren | |
| WO2005009965A8 (en) | Nicotinamide derivatives useful as pde4 inhibitors | |
| ATE297902T1 (de) | Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren | |
| MX2007001952A (es) | Compuestos y composiciones utiles como inhibidores de catepsina-s. |